Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats

Critical Care Medicine

Volumn 25, Issue 6, 1997, Pages 1037-1043

  Miyabe, Masayuki ^a   Kirsch, Jeffrey R ^a   Nishikawa, Toshiaki ^a   Koehler, Raymond C ^a   Traystman, Richard J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cerebral blood flow; CGS 19755; Excitatory amino acids; Middle cerebral artery occlusion; MK 801; NPC 17742; Sematosensory evoked potential

Indexed keywords

2 AMINO 4,5 (1,2 CYCLOHEXYL) 7 PHOSPHONOHEPTANOIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PROTECTION; CAT; CONTROLLED STUDY; EVOKED SOMATOSENSORY RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK;

AMINO ACIDS; ANIMALS; BRAIN; BRAIN DAMAGE, CHRONIC; CATS; CEREBROVASCULAR CIRCULATION; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS; PIPECOLIC ACIDS; PROSPECTIVE STUDIES; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030951354     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199706000-00022     Document Type: Article

References (34)

1. Hagberg H, Lehmann A, Sandberg M, et al: Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. J Cereb Blood Flow Metab 1985; 5:413-419
2. Rothman SM, Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986; 19:105-111
3. Obrenovitch TP, Richards DA: Extracellular neurotransmitter changes in cerebral ischaemia. Cerebrovasc Brain Metab Rev 1995; 7:1-54
4. Muir KW, Lees KR: Clinical experience with excitatory amino acid antagonist drugs. Stroke 1995; 26: 503-513
5. Iijima T, Mies G, Hossmann K-A: Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK-801: Effect on volume of ischemic injury. J Cereb Blood Flow Metab 1992; 12: 727-733
6. Gill R, Andine P, Hillered L, et al: The effect of MK-801 on cortical spreading depression in the penumbral zone following focal ischemia in the rat. J Cereb Blood Flow Metab 1992; 12: 371-379
7. Sauer D, Allegrini PR, Cosenti A, et al: Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: An in vivo magnetic resonance imaging study. J Cereb Blood Flow Metab 1993; 13:595-602
8. Bullock R, Graham DI, Chen MH, et al: Focal cerebral ischemia in the cat: Pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene. J Cereb Blood Flow Metab 1990; 10: 668-674
9. Dezsi L, Greenberg JH, Hamar J, et al: Acute improvement in histological outcome by MK-801 following focal ischemia and reperfusion in the cat independent of blood flow changes. J Cereb Blood Flow Metab 1992; 12:390-399
10. Ozyurt E, Graham DI, Woodruff GN, et al: Protective effect of the glutamate antagonist, MK-801, in focal cerebral ischemia in the cat. J Cereb Blood Flow Metab 1988; 8:138-143
11. Park CK, Nehls DG, Graham DI, et al: Focal cerebral ischemia in the cat: Treatment with the glutamate antagonist MK-801 after induction of ischemia. J Cereb Blood Flow Metab 1988; 8:757-762
12. Ferkany JW, Hamilton GS, Patch RJ, et al: Pharmacological profile of NPC 17742, a potent, selective and competitive N-methyl-D-aspartate receptor antagonist. J Pharmacol Exp Ther 1993; 264:256-264
13. Nishikawa T, Kirsch JR, Koehler RC, et al: Competitive N-methyl-D-aspartate receptor blockade reduces brain injury following transient focal ischemia in cats. Stroke 1994; 25:2258-2264
14. Madden KP, Clark WM, Zivin JA: Delayed therapy of experimental ischemia with competitive N-methyl-D-aspartate antagonists in rabbits. Stroke 1993; 24:1068-1071
15. Matsumiya N, Koehler RC, Traystman RJ: Consistency of cerebral blood flow and evoked potential alterations with reversible focal ischemia in cats. Stroke 1990; 21:908-916
16. Matsumiya N, Koehler RC, Kirsch JR, et al: Conjugated superoxide dismutase reduces extent of caudate injury after transient focal ischemia in cats. Stroke 1991; 22:1193-1200
17. Heymann MA, Payne BD, Hoffman JI, et al: Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis 1977; 20:55-79
18. Bederson JB, Pitts LH, Germano SM, et al: Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986; 17:1304-1308
19. Cole DJ, Drummond JC, Ghazal EA, et al: A reversible component of cerebral injury as identified by the histochemical stain 2,3,5-triphenyltetrazolium chloride (TTC). Acta Neuropathol (Berl) 1990; 80:152-155
20. Takeshima R, Kirsch JR, Koehler RC, et al: Monoclonal leukocyte antibody (MoAb 60.3) does not decrease injury following transient focal cerebral ischemia in cats. Stroke 1992; 23: 247-252
21. Roussel S, Pinard E, Seylaz J: The acute effects of MK-801 on cerebral blood flow and tissue partial pressures of oxygen and carbon dioxide in conscious and alpha-chloralose anaesthetized rats. Neuroscience 1992; 47:959-965
22. 2 during hypoglycemia in piglets. Am J Physiol 1993; 264:H2124-H2130
23. Olney JW, Labruyere J, Price MT: Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989; 244: 1360-1362
24. Sharp FR, Jasper P, Hall J, et al: MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann Neurol 1991; 30:801-809
25. Perez-Pinzon MA, Maier CM, Sun GH, et al: CGS 19755: Correlation of in vitro neuroprotection, protection against experimental ischemia and CSF levels in cerebrovascular surgery patients. Abstr. Stroke 1995; 26:27
26. Grotta J, Clark W, Coull B, et al: Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a Phase IIa randomized trial. Stroke 1995; 26:602-605
27. Kaku DA, Giffard RG, Choi DW: Neuroprotective effects of glutamate antagonists and extracellular acidity. Science 1993; 260:1516-1518
28. Lauritzen M, Hansen AJ: The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J Cereb Blood Flow Metab 1992; 12:223-229
29. Lo EH, Matsumoto K, Pierce AR, et al: Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia. J Cereb Blood Flow Metab 1994; 14:597-603
30. Wahl F, Obrenovitch TP, Hardy AM, et al: Extracellular glutamate during focal cerebral ischaemia in rats: Time course and calcium-dependency. J Neurochem 1994; 63:1003-1011
31. Steinberg GK, Saleh J, Kunis D, et al: Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits. Stroke 1989; 20:1247-1252
32. Meyer FB, Anderson RE, Friedrich PF: MK-801 attenuates capillary bed compression and hypoperfusion following incomplete focal cerebral ischemia. J Cereb Blood Flow Metab 1990; 10: 895-902
33. Takizawa S, Hogan M, Hakim AM: The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia. J Cereb Blood Flow Metab 1991; 11: 786-793
34. Park CK, Nehls DG, Teasdale GM, et al: Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 1989; 9:617-622